Page last updated: 2024-08-18

pyridostigmine bromide and Adenoma

pyridostigmine bromide has been researched along with Adenoma in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (40.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Karavitaki, N; Stylianidou, C; Thalassinos, NC; Tsagarakis, S; Tzanela, M	1
Karavitaki, N; Stylianidou, Ch; Thalassinos, NC; Tsagarakis, S; Tzanela, M; Zianni, D	1
Bieglmayer, C; Nardi, A; Vierhapper, H	1
Bossoni, S; Buffoli, MG; Ferrari, C; Giustina, A; Pozzi, A; Scalvini, T; Schettino, M	1
Bodini, C; Bossoni, S; Ferrari, C; Giustina, A; Pizzocolo, G; Scalvini, T; Schettino, M; Wehrenberg, WB	1

Trials

1 trial(s) available for pyridostigmine bromide and Adenoma

Article	Year
Pyridostigmine enhances even if it does not normalize the growth hormone responses to growth hormone-releasing hormone in patients with Cushing's disease. Hormone research, 1991, Volume: 35, Issue:3-4 Topics: Adenoma; Administration, Oral; Adult; Antibodies, Monoclonal; Cushing Syndrome; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Injections, Intravenous; Pituitary Neoplasms; Pyridostigmine Bromide; Radioimmunoassay	1991

Article

Year

Pyridostigmine enhances even if it does not normalize the growth hormone responses to growth hormone-releasing hormone in patients with Cushing's disease.

Hormone research, 1991, Volume: 35, Issue:3-4

Topics: Adenoma; Administration, Oral; Adult; Antibodies, Monoclonal; Cushing Syndrome; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Injections, Intravenous; Pituitary Neoplasms; Pyridostigmine Bromide; Radioimmunoassay

1991

Other Studies

4 other study(ies) available for pyridostigmine bromide and Adenoma

Article	Year
Assessment of GH reserve before and after successful treatment of adult patients with Cushing's syndrome. Clinical endocrinology, 2004, Volume: 60, Issue:3 Topics: ACTH Syndrome, Ectopic; Adenoma; Adrenal Cortex; Adrenal Cortex Neoplasms; Adult; Aged; Cholinesterase Inhibitors; Cushing Syndrome; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Insulin; Insulin-Like Growth Factor I; Male; Middle Aged; Pyridostigmine Bromide; Statistics, Nonparametric	2004
Evaluation of GH reserve in patients with adrenal incidentalomas and biochemical evidence of subclinical autonomous glucocorticoid hypersecretion. Clinical endocrinology, 2005, Volume: 62, Issue:5 Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Aged; Analysis of Variance; Cholinesterase Inhibitors; Dexamethasone; Female; Glucocorticoids; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hydrocortisone; Incidental Findings; Male; Middle Aged; Predictive Value of Tests; Pyridostigmine Bromide; Statistics, Nonparametric	2005
The use of the pyridostigmine growth hormone-releasing hormone stimulation test to detect growth hormone deficiency in patients with pituitary adenomas. Metabolism: clinical and experimental, 2002, Volume: 51, Issue:1 Topics: Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Aging; Body Mass Index; Female; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Male; Middle Aged; Pituitary Neoplasms; Pyridostigmine Bromide	2002
Effect of pretreatment with pyridostigmine on the thyrotropin response to thyrotropin-releasing hormone in patients with Cushing's disease. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1992, Volume: 24, Issue:5 Topics: Adenoma; Adult; Cushing Syndrome; Drug Interactions; Female; Humans; Middle Aged; Pituitary Neoplasms; Pyridostigmine Bromide; Radioimmunoassay; Thyrotropin; Thyrotropin-Releasing Hormone	1992